201 = 54%18 Aug 2021 23:56
Don’t forget the science which others on here say formulas at 30% success rates being in big bucks, a couple of snipers from the 201 data results below.
VAL201 Clinical Trial Full Data Results
Full dataset confirms VAL201 is a safe and well-tolerated drug candidate
Disease Impact
-- The headline results released in the Company announcement on 28 September 2020 highlighted the response rate of 54.5%, where response was confirmed by a lack of disease progression by PCWG2 (Prostate Cancer Working Group 2) criteria. The dataset now received provides the detailed breakdown of this by providing both the PSA modulation afforded by the treatment, and the tumour response.